Stay updated with breaking news from Sure Predict. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Diadem SpA, a company developing AlzoSure® Predict, the first blood-based test for the early prediction of progression to Alzheimer's disease...
/PRNewswire/ -- Diadem SpA today announced publication of the results of a clinical validation study of its AlzoSure® Predict prognostic blood test for...
European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease - read this article along with other careers information, tips and advice on BioSpace
Diadem has secured CE-IVD certification for its non-invasive plasma-based AlzoSure Predict blood test for predicting Alzheimer's disease (AD)
Diadem Presents Clinical Data and Commercialization Plans for Its AlzoSure® Prognostic Biomarker Test at 2020 Alzheimer's Disease International Conference -- Blood-Based AlzoSure Assay Has Potential to Transform Management of Alzheimer's Disease by Identifying Patients Early in the Disease Process -- News provided by Share this article Share this article MILAN, Dec. 11, 2020 /PRNewswire/ -- Diadem srl, a company developing the first blood-based test for the early prediction of Alzheimer's disease (AD), today reported that it hosted a Symposium on its prognostic biomarker test at the 34 th A...